Hepion Pharmaceuticals, Inc. (HEPA)
NASDAQ: HEPA · Real-Time Price · USD
0.690
0.00 (0.00%)
Nov 21, 2024, 4:00 PM EST - Market closed
Hepion Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 4 | 14 | 23 | 87 | 70 | 19 | |
| Market Cap Growth | -79.71% | -38.61% | -73.66% | 23.90% | 278.86% | 301.66% | |
| Enterprise Value | 6 | -3 | -34 | -10 | 59 | 6 | |
| Last Close Price | 0.69 | 3.24 | 6.01 | 22.80 | 43.80 | 107.20 | |
| PB Ratio | -9.55 | 1.93 | 0.46 | 0.93 | 1.73 | 1.19 | |
| P/TBV Ratio | - | 2.52 | 0.51 | 1.01 | 2.08 | 2.09 | |
| Debt / Equity Ratio | -5.47 | 0.03 | 0.00 | 0.00 | 0.02 | 0.05 | |
| Quick Ratio | 0.77 | 2.80 | 6.49 | 11.13 | 8.74 | 8.65 | |
| Current Ratio | 1.30 | 3.31 | 7.16 | 11.88 | 9.15 | 8.94 | |
| Return on Equity (ROE) | -288.27% | -171.26% | -59.08% | -49.02% | -72.52% | -80.01% | |
| Return on Assets (ROA) | -110.40% | -72.22% | -33.29% | -24.97% | -36.36% | -33.72% | |
| Return on Capital (ROIC) | -174.03% | -98.56% | -38.07% | -28.24% | -43.65% | -48.96% | |
| Earnings Yield | -559.31% | -348.13% | -184.35% | -37.66% | -29.02% | -38.01% | |
| FCF Yield | -642.11% | -291.04% | -152.80% | -36.08% | -23.17% | -41.14% | |
| Buyback Yield / Dilution | -44.02% | -4.18% | -8.45% | -626.31% | -373.65% | - | |
| Total Shareholder Return | -44.02% | -4.18% | -8.45% | -626.31% | -373.65% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.